Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients

Laure Écotière(Centre National de la Recherche Scientifique), Frank Bridoux(Université de Poitiers), Sihem Kaaki(Université de Poitiers), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Vincent Javaugue(Université de Poitiers), Nathalie Quellard(Université de Poitiers), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Sylvie Chevret(Saint Louis University Hospital), Antoine Thierry(Université de Poitiers), Céline Debiais-Delpech, Jean‐Paul Fermand(Sorbonne Université), Jean Michel Goujon(Université de Poitiers), S. Belmouaz(Université de Poitiers)
Nephrology Dialysis Transplantation
March 10, 2016
10.1093/ndt/gfw056
Cited by 14

Related Papers

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
|Blood|1999|745
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
|The Lancet Oncology|2014|703